-
Mashup Score: 14The Future of Cardiology - Value-Based Care, Private Equity and the Practice Landscape - American College of Cardiology - 15 day(s) ago
It’s becoming increasingly evident that alongside top-notch clinical expertise, the CV specialist of the future must be surrounded by a multi-talented, diverse team to provide optimal patient care. In addition, it is crucial that the clinician and CV organization engage in non-clinical competencies to enhance value for patients, the healthcare system, and society. MedAxiom and ACC collaborate synergistically toward achieving these goals. In this interview, Jerry Blackwell MD, MBA, FACC and Joseph E.
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 19
This episode covers a review on disparities in cardiovascular perioperative health care. The writers propose actionable solutions utilizing multidisciplinary perspectives from cardiology, cardiac surgery, cardiothoracic anesthesiology, critical care, medical ethics, and health disparity experts. In this interview, Adam J. Milam, MD, PhD, and Clyde W.Yancy, MD, MSc, MACC, discuss the JACC State-of-the-Art Review: Racial and Ethnic Disparities in Perioperative Health Care Among Patients Undergoing Cardiac
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 5
A study provides new data for patients with genetic heart disease (GHD) and exercise recommendations. For decades, those with GHD were excluded from exercise and sports participation. This has led to poor exercise tolerance, increased risk for CAD and poor outcomes in this group related to reduced fitness. This study helps frame that those with GHD are unique and as a result, require an individualized approach to care. After expert consultation, patients with GHD can often be safe to participate in
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 16AHA Late-Breaker ARTESiA: Apixaban for the Prevention of Stroke in Patients With Subclinical AF - American College of Cardiology - 2 month(s) ago
Continuous cardiac monitoring detects brief, asymptomatic, heart rhythm abnormalities in one-third of older individuals and these symptoms are associated with an increased risk of stroke. The ARTESiA trial clearly demonstrates that use of the blood thinner apixaban reduces patient risk of stroke compared to treatment with aspirin, but is associated with an increased risk of bleeding. In…
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 18ACCEL Lite: Behind the ACC 2023 Guideline for Chronic CAD: Conversations and Controversies - American College of Cardiology - 2 month(s) ago
The 2023 guideline provides an evidenced-based and patient-centered approach to management of patients with chronic coronary disease, considering social determinants of health and incorporating the principles of shared decision-making and team-based care. In this interview, Kristin Newby, MD, FACC, and Nanette Kass Wenger MD, MACC, discuss Behind the ACC 2023 Guideline for Chronic CAD: Conversations and Controversies. Keywords: ACCELLite, Coronary Artery
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 20ACCEL Lite: Top Takeaways from the ACC 2023 Guideline for Chronic CAD for the Practicing Clinician - American College of Cardiology - 3 month(s) ago
To improve our understanding of the basic principles in the treatment and management of patients with chronic heart disease, in this interview, Salim S. Virani, MD, PhD, FACC, and Roger S. Blumenthal, MD, FACC, discuss top takeaways from the ACC 2023 Guideline for Chronic
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 6
The SELECT trial extends findings from previous trials, which demonstrated cardiovascular benefit in diabetes mellitus (DM), to those without DM. In this interview, Abraham Lincoff, MD, FACC, and Glenn A. Hirsch MD, MHS, FACC, discuss AHA Late-Breaker: SELECT – Semaglutide and Cardiovascular Outcomes in Patients with Overweight or Obesity Who Do Not Have Diabetes. Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, Lingvay I,
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 11ACCEL Lite: Top Takeaways from 2023: Preventive Cardiology with Noel Bairey Merz, MD, FACC - American College of Cardiology - 4 month(s) ago
In this interview, Noel Bairey Merz, MD, FACC, and Alison L. Bailey, MD, FACC discuss the top takeaways from 2023 in Preventive Cardiology including the CLEAR-Outcomes, REPRIEVE, and SELECT trials. Related References: Lincoff, A. M., Brown‐Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., Hardt‐Lindberg, S., Hovingh, G. K., Kahn, S….
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 5
Results of this trial indicate tha t dapagliflozin treatment immediately after an acute heart attack reduced adverse cardiovascular and metabolic outcomes. In this interview, Stefan James MD, PhD and Laxmi Mehta MD, FACC, discuss AHA Late-Breaker: DAPA-MI – A Registry-Based Randomized Trial of Dapagliflozin in Patients With Acute Myocardial Infarction Without Diabetes. James S, Erlinge D, Storey RF, McGuire DK, de Belder M, Björkgren I, Johansson PA, Langkilde AM, Ridderstråle W, Parvaresh Rizi E,
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 10ACCEL Lite: Cardiovascular Safety of Testosterone-Replacement Therapy - American College of Cardiology - 6 month(s) ago
Testosterone is widely prescribed to aging men but there have been concerns about heart-related safety. The FDA mandat ed that the makers of testosterone products conduct a trial to determine if these drugs increase the risk of heart attack or stroke. In this interview, Steven E. Nissen, MD, MACC, and William E. Boden MD, FACC, discuss Cardiovascular Safety of Testosterone-Replacement Therapy Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, Cunningham GR, Granger CB, Khera M, Thompson
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
It's crucial the clinician & CV organization engage in non-clinical competencies to enhance value for patients, the healthcare system & society. Drs. Jerry Blackwell & @DrJMarine discuss "The Future of Cardiology" on the #ACCEL Lite podcast. Listen here: https://t.co/fAKhvkxy7h https://t.co/lCTKu8em8w